GDRX logo

GoodRx Holdings (GDRX) Cash From Investing

Annual CFI

-$55.77 M
+$154.73 M+73.51%

31 December 2023

GDRX Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

-$15.86 M
+$1.37 M+7.95%

30 September 2024

GDRX Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

-$66.58 M
-$2.21 M-3.44%

30 September 2024

GDRX TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GDRX Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+73.5%-16.2%-60.0%
3 y3 years+39.1%+41.4%+62.9%
5 y5 years-1512.7%--

GDRX Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+73.5%-1333.2%+90.3%-60.0%+71.6%
5 y5 years-1512.7%+73.5%-1333.2%+90.3%-1854.1%+71.6%
alltimeall time-1512.7%+73.5%-1333.2%+90.3%-1854.1%+71.6%

GoodRx Holdings Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$15.86 M(-8.0%)
-$66.58 M(+3.4%)
June 2024
-
-$17.23 M(-16.4%)
-$64.36 M(+3.7%)
Mar 2024
-
-$20.61 M(+60.2%)
-$62.09 M(+11.3%)
Dec 2023
-$55.77 M(-73.5%)
-$12.87 M(-5.7%)
-$55.77 M(+34.0%)
Sept 2023
-
-$13.65 M(-8.8%)
-$41.61 M(-0.3%)
June 2023
-
-$14.96 M(+4.7%)
-$41.74 M(-78.1%)
Mar 2023
-
-$14.29 M(-1211.0%)
-$190.38 M(-9.6%)
Dec 2022
-$210.50 M
$1.29 M(-109.3%)
-$210.50 M(-4.8%)
Sept 2022
-
-$13.78 M(-91.6%)
-$221.04 M(-5.7%)
June 2022
-
-$163.61 M(+375.6%)
-$234.33 M(+15.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$34.40 M(+271.5%)
-$203.44 M(+13.8%)
Dec 2021
-$178.73 M(+95.1%)
-$9.26 M(-65.8%)
-$178.73 M(-0.3%)
Sept 2021
-
-$27.06 M(-79.6%)
-$179.28 M(-20.6%)
June 2021
-
-$132.72 M(+1269.0%)
-$225.71 M(+130.5%)
Mar 2021
-
-$9.70 M(-1.2%)
-$97.91 M(+6.9%)
Dec 2020
-$91.62 M(+147.2%)
-$9.81 M(-86.7%)
-$91.62 M(+12.0%)
Sept 2020
-
-$73.49 M(+1396.1%)
-$81.81 M(+883.4%)
June 2020
-
-$4.91 M(+44.2%)
-$8.32 M(+144.2%)
Mar 2020
-
-$3.41 M
-$3.41 M
Dec 2019
-$37.05 M(+971.6%)
-
-
Dec 2018
-$3.46 M
-
-

FAQ

  • What is GoodRx Holdings annual cash flow from investing activities?
  • What is the all time high annual CFI for GoodRx Holdings?
  • What is GoodRx Holdings annual CFI year-on-year change?
  • What is GoodRx Holdings quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for GoodRx Holdings?
  • What is GoodRx Holdings quarterly CFI year-on-year change?
  • What is GoodRx Holdings TTM cash flow from investing activities?
  • What is the all time high TTM CFI for GoodRx Holdings?
  • What is GoodRx Holdings TTM CFI year-on-year change?

What is GoodRx Holdings annual cash flow from investing activities?

The current annual CFI of GDRX is -$55.77 M

What is the all time high annual CFI for GoodRx Holdings?

GoodRx Holdings all-time high annual cash flow from investing activities is -$3.46 M

What is GoodRx Holdings annual CFI year-on-year change?

Over the past year, GDRX annual cash flow from investing activities has changed by +$154.73 M (+73.51%)

What is GoodRx Holdings quarterly cash flow from investing activities?

The current quarterly CFI of GDRX is -$15.86 M

What is the all time high quarterly CFI for GoodRx Holdings?

GoodRx Holdings all-time high quarterly cash flow from investing activities is $1.29 M

What is GoodRx Holdings quarterly CFI year-on-year change?

Over the past year, GDRX quarterly cash flow from investing activities has changed by -$2.21 M (-16.21%)

What is GoodRx Holdings TTM cash flow from investing activities?

The current TTM CFI of GDRX is -$66.58 M

What is the all time high TTM CFI for GoodRx Holdings?

GoodRx Holdings all-time high TTM cash flow from investing activities is -$3.41 M

What is GoodRx Holdings TTM CFI year-on-year change?

Over the past year, GDRX TTM cash flow from investing activities has changed by -$24.97 M (-60.01%)